111, Inc. Hosts Hua Medicine Launches First Official Flagship Store
On February 15, 2023, 111, Inc. ("111" or the "Company") (NASDAQ:YI), a leading tech-enabled healthcare platform company in China, announced that during the HuaTangNing®
Charter Communications, Braze And Some Other Big Stocks Moving Lower In Today’s Pre-Market Session
U.S. stock futures traded slightly higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.
iQIYI, Inc. (NASDAQ: IQ) shares dipped 14.1% to $3.31 in pre-market trading after gaining over 9% on Tuesday.
Reuters Reported Earlier China’s 111.inc App Starts Retail Sales of Pfizer’s Paxlovid for COVID
https://www.reuters.com/business/healthcare-pharmaceuticals/chinas-111inc-app-starts-retail-sales-pfizers-paxlovid-covid-treatment-2022-12-13/
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday’s Mid-Day Session
Gainers
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Earnings Scheduled For December 1, 2022
Companies Reporting Before The Bell
• 111 (NASDAQ:YI) is expected to report earnings for its third quarter.
111 Inc. Received Unsolicited Preliminary Non-Binding Proposal to Acquire the Company for $3.66/ADS in Cash
111 Inc. ( "111" or the "Company") (NASDAQ: YI) today announced that its Board of Directors (the "Board") has received an unsolicited preliminary non-binding proposal letter (the "Proposal") dated September 9, 2022 jointly submitted by Dr. Gang Yu, co-founder and co-chairman of the Company, Mr.
Earnings Scheduled For June 16, 2022
Companies Reporting Before The Bell
• Commercial Metals (NYSE:CMC) is expected to report quarterly earnings at $1.98 per share on revenue of $2.41 billion.
70 Biggest Movers From Friday
Gainers
Avadel Pharmaceuticals plc (NASDAQ: AVDL) shares climbed 133.6% to close at $2.50 on Friday. Avadel Pharmaceuticals shares dipped 68% on Thursday after announcing new FDA request for experimental narcolepsy drug.
